FDA Drug Application (200532) for OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE by TEVA PHARMS USA INC

Back to FDA Applications sponsored by TEVA PHARMS USA INC

Application Number200532
Product Number001
FormTABLET; ORAL
Dosage20MG; 12.5MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameOLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE
Active IngredientOLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient OLMESARTAN MEDOXOMIL11


Back to FDA Applications sponsored by TEVA PHARMS USA INC